Unknown News
Unknown Market News
3d
Clorox Outlines Fiscal 2027 Organic Sales Growth of 3.5–4.5% at Boston Staples Conference
- At the Boston Global Staples Conference (Sept 9), Clorox forecasts fiscal 2027 organic sales growth of 3.5–4.5%, citing operational improvements and health‑hygiene expansion.
10d
Clorox Schedules Presentation at Barclays Global Consumer Staples Conference on Sept. 9
Clorox (CLX) is set to present at the Barclays Global Consumer Staples Conference on September 9, offering a key opportunity to update investors on strategy amid recent market pressure.
17d
Clorox Schedules Fireside Chat at Barclays Conference Following FY26 Results
Clorox is set to appear Sept. 9 at Barclays Global Consumer Staples Conference after reporting FY26 results and raising its dividend.
24d
Clorox Lifts Fiscal 2027 Outlook Following Q4 Beat and GOJO Acquisition
Clorox beat Q4 expectations and raised FY2027 guidance, driven by its April GOJO acquisition and improving demand in health & wellness, according to Reuters.
19 Aug at 01:41
Barclays Lowers Clorox Price Target Amid Pricing Strategy Concerns
Barclays reduces Clorox's price target to $84 due to pricing strategy concerns.
01 Aug at 08:46
Clorox Faces Declining Sales and Market Pressure in Q3 FY2026
On April 30, 2026, The Clorox Company reported its third-quarter fiscal year 2026 results, revealing flat net sales and a downward revision of its full-year guidance. This announcement led to a significant decline in the company's stock price, which reached a 52-week low of $88.38.
